ZDA
AGL icon

Zweig-DiMenna Associates’s Agilon Health AGL Stock Holding History

Zweig-DiMenna Associates’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,814
Closed -$1.8M – 79
2024
Q1 		$1.8M Hold
11,814
– – 0.16% 97
2023
Q4 		$3.71M Buy
+11,814
New +$4.28M 0.42% 66

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zweig-DiMenna Associates's AGL Position: Q2 2024 in Review

Zweig-DiMenna Associates sold out of Agilon Health (AGL) in Q2 2024, closing a stake of 11,814 shares — an estimated $1.8M sold.

Zweig-DiMenna Associates first reported a position in AGL in Q4 2023 and held it in 2 quarters. The position peaked at $3.71M in Q4 2023. 201 funds tracked by Wall St. Rank hold AGL as of Q2 2024.

  • Zweig-DiMenna Associates reported no remaining Agilon Health position as of Q2 2024 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 11,814 Agilon Health shares in Q2 2024, an estimated $1.8M.
  • Zweig-DiMenna Associates first reported a position in Agilon Health in Q4 2023 and held it in 2 quarters.
  • Zweig-DiMenna Associates's Agilon Health position peaked at $3.71M in Q4 2023.
  • 201 funds tracked by Wall St. Rank held Agilon Health as of Q2 2024.

Based on Zweig-DiMenna Associates's 13F filing for Q2 2024, filed 24 Jul 2024.